● Cosmetic Dissolving Microneedle Patch OEM‑ODM ● Private‑Label & Custom Formulation ● GHK‑Cu Copper Peptide Microneedle Patches ● Acetyl Hexapeptide‑8 Eye Patches ● Palmitoyl Peptide Patch Concepts ● Multi‑Peptide Dissolvable Patches ● Microneedle Eye Patches & Facial Patches ● Sample Prototypes to Mass Manufacturing ● Flexible MOQ ● Global B2B Export Service ● Cosmetic‑Grade Formulation ● Packaging Customization ● Batch QC Documents ● Samples & Bulk Orders ● Request OEM Quote ●
B2B OEM / ODM

Dissolvable Microneedle Patch Products

Custom cosmetic microneedle patch formats for beauty brands, private-label buyers and global distributors.

Explore dissolvable cosmetic microneedle patch platforms for targeted skincare, private label and custom OEM / ODM programs.

HYTANBIO · CHANGZHOU BASE

Explore the extended configuration portfolio

Compare the HA patch range with solid PLA components, roller systems and separately reviewed research concepts. The portfolio connects material selection, nominal geometry, formulation and packaging in one project brief.

02 / Explore

Solid PLA tools →

Delivery heads, applicator patches, silicone support and sheets.

View all 30 configurations and the source portfolio →

Scope note: Product examples describe potential cosmetic development directions, not stocked finished goods or guaranteed claims. Feasibility, evidence and regulatory requirements are confirmed project by project. GLP-1 receptor agonists are outside this cosmetic OEM scope; see the GLP-1 and Retatrutide compliance guide.
Direct answers for OEM buyers

Questions buyers ask before the next step

The following answers convert this page into a decision-ready reference rather than a general marketing summary. Each answer states the conclusion first and then names the variables that can change it. Numerical values such as MOQ, lead time, active content, dimensions, shelf life and price are not presented as universal facts when they depend on an unapproved project specification. This makes the page easier for both human buyers and AI systems to quote accurately: confirmed company or process information remains separate from product-specific assumptions, while cosmetic, medical and jurisdictional boundaries stay visible. For a live project, use these answers to prepare the brief and request the supporting specification, test or contractual record. Mark unresolved inputs as open actions with an owner and due date, then update the controlled project version after evidence is reviewed.

Are the products shown ready-made stock items?

No. The portfolio describes potential cosmetic development directions and configurable patch platforms. Availability, formula composition, ingredient content, patch dimensions, evidence, pack format, MOQ and timing require project confirmation. A listed concept should not be interpreted as a guaranteed finished product, regulatory approval or supported claim in every market.

How should a brand choose its first microneedle patch format?

Begin with one application area, one clear cosmetic benefit and a realistic retail price. Then align patch contour, array area, formula, wearing instructions and pack count with the target user and channel. A focused hero SKU usually creates cleaner sampling, evidence, inventory and reorder decisions than an untested multi-SKU launch.

Can pharmaceutical peptides be substituted for cosmetic peptides?

No. Drug substances and investigational peptides are not interchangeable with cosmetic ingredients. Semaglutide, Tirzepatide, Retatrutide and related GLP-1 drug concepts are outside the cosmetic OEM scope described on this site. Ingredient status, intended use, claims and delivery mechanism must be reviewed before any development pathway is selected.

Content review: Last reviewed October 15, 2026. Material changes to formula, claims, manufacturing scope or target market require a fresh review.

Get OEM Quote